These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32216755)

  • 1. Modelling of viral load dynamics and CD4 cell count progression in an antiretroviral naive cohort: using a joint linear mixed and multistate Markov model.
    Dessie ZG; Zewotir T; Mwambi H; North D
    BMC Infect Dis; 2020 Mar; 20(1):246. PubMed ID: 32216755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modelling immune deterioration, immune recovery and state-specific duration of HIV-infected women with viral load adjustment: using parametric multistate model.
    Dessie ZG; Zewotir T; Mwambi H; North D
    BMC Public Health; 2020 Mar; 20(1):416. PubMed ID: 32228523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of viral load rebound on HIV/AIDS patients receiving antiretroviral therapy: results from South Africa.
    Shoko C; Chikobvu D
    Theor Biol Med Model; 2018 Jul; 15(1):10. PubMed ID: 30008270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling Viral Suppression, Viral Rebound and State-Specific Duration of HIV Patients with CD4 Count Adjustment: Parametric Multistate Frailty Model Approach.
    Dessie ZG; Zewotir T; Mwambi H; North D
    Infect Dis Ther; 2020 Jun; 9(2):367-388. PubMed ID: 32318999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modelling HIV disease process and progression in seroconversion among South Africa women: using transition-specific parametric multi-state model.
    Dessie ZG; Zewotir T; Mwambi H; North D
    Theor Biol Med Model; 2020 Jun; 17(1):10. PubMed ID: 32571361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress towards the UNAIDS 90-90-90 goals by age and gender in a rural area of KwaZulu-Natal, South Africa: a household-based community cross-sectional survey.
    Huerga H; Van Cutsem G; Ben Farhat J; Puren A; Bouhenia M; Wiesner L; Dlamini L; Maman D; Ellman T; Etard JF
    BMC Public Health; 2018 Mar; 18(1):303. PubMed ID: 29499668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Antiretroviral Therapy on CD4+ Cell Count, HIV Viral Load and Death in a South African Cohort: A Modelling Study.
    Shoko C; Chikobvu D; Bessong PO
    Pak J Biol Sci; 2020 Mar; 23(4):542-551. PubMed ID: 32363840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multilevel ordinal model for CD4 count trends in seroconversion among South Africa women.
    Dessie ZG; Zewotir T; Mwambi H; North D
    BMC Infect Dis; 2020 Jun; 20(1):447. PubMed ID: 32576220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of CD4+ lymphocyte count, viral load, and duration of taking anti-retroviral treatment on presence of oral lesions in a sample of South African children with HIV+/AIDS.
    Duggal MS; Abudiak H; Dunn C; Tong HJ; Munyombwe T
    Eur Arch Paediatr Dent; 2010 Oct; 11(5):242-6. PubMed ID: 20932399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-financing for viral load monitoring during the course of antiretroviral therapy among patients with HIV/AIDS in Vietnam: A contingent valuation survey.
    Nguyen QL; Nguyen LH; Tran BX; Phan HT; Le HT; Nguyen HD; Tran TD; Do CD; Nguyen CM; Thuc VT; Latkin C; Zhang MW; Ho RC
    PLoS One; 2017; 12(2):e0172050. PubMed ID: 28199405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the health-related quality of life, CD4 count and viral load of AIDS patients and people with HIV who have been on treatment for 12 months in rural South Africa.
    Igumbor J; Stewart A; Holzemer W
    SAHARA J; 2013 Mar; 10(1):25-31. PubMed ID: 23777555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa.
    Shoko C; Chikobvu D
    Theor Biol Med Model; 2018 Jan; 15(1):3. PubMed ID: 29343268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4+ T-cell Count may not be a Useful Strategy to Monitor Antiretroviral Therapy Response in HTLV-1/HIV Co-infected Patients.
    Vandormael A; Rego F; Danaviah S; Carlos Junior Alcantara L; Boulware DR; de Oliveira T
    Curr HIV Res; 2017; 15(3):225-231. PubMed ID: 28215175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Markov modelling of viral load adjusting for CD4 orthogonal variable and multivariate conditional autoregressive mapping of the HIV immunological outcomes among ART patients in Zimbabwe.
    Matsena Zingoni Z; Chirwa TF; Todd J; Musenge E
    Theor Biol Med Model; 2021 Aug; 18(1):16. PubMed ID: 34419087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.
    Skiest DJ; Su Z; Havlir DV; Robertson KR; Coombs RW; Cain P; Peterson T; Krambrink A; Jahed N; McMahon D; Margolis DM;
    J Infect Dis; 2007 May; 195(10):1426-36. PubMed ID: 17436222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined estimation of disease progression and retention on antiretroviral therapy among treated individuals with HIV in the USA: a modelling study.
    Wang L; Krebs E; Min JE; Mathews WC; Nijhawan A; Somboonwit C; Aberg JA; Moore RD; Gebo KA; Nosyk B;
    Lancet HIV; 2019 Aug; 6(8):e531-e539. PubMed ID: 31303557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 and viral load dynamics in antiretroviral-naïve HIV-infected adults from Soweto, South Africa: a prospective cohort.
    Martinson NA; Gupte N; Msandiwa R; Moulton LH; Barnes GL; Ram M; Gray G; Hoffmann C; Chaisson RE
    PLoS One; 2014; 9(5):e96369. PubMed ID: 24831447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of treatment outcomes for patients on first-line regimens in US President's Emergency Plan for AIDS Relief (PEPFAR) clinics in Uganda: predictors of virological and immunological response from RV288 analyses.
    Crawford KW; Wakabi S; Magala F; Kibuuka H; Liu M; Hamm TE
    HIV Med; 2015 Feb; 16(2):95-104. PubMed ID: 25124078
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV viral load as an independent risk factor for tuberculosis in South Africa: collaborative analysis of cohort studies.
    Fenner L; Atkinson A; Boulle A; Fox MP; Prozesky H; Zürcher K; Ballif M; Furrer H; Zwahlen M; Davies MA; Egger M;
    J Int AIDS Soc; 2017 Jun; 20(1):21327. PubMed ID: 28691438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.